Chargari Cyrus, Haie-Meder Christine, Guérin Florent, Minard-Colin Véronique, de Lambert Guénolée, Mazeron Renaud, Escande Alexandre, Marsolat Fanny, Dumas Isabelle, Deutsch Eric, Valteau-Couanet Dominique, Audry Georges, Oberlin Odile, Martelli Hélène
Brachytherapy Unit, Department of Radiotherapy, Gustave Roussy, Villejuif, France; Institut de Recherche Biomédicale des Armées, Bretigny-sur-Orge, France; French Military Health Service Academy, Ecole du Val-de-Grâce, Paris, France.
Brachytherapy Unit, Department of Radiotherapy, Gustave Roussy, Villejuif, France.
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):352-359. doi: 10.1016/j.ijrobp.2017.02.026. Epub 2017 Feb 21.
To report the results of a conservative strategy based on partial surgery combined with brachytherapy in a prospective cohort of children with bladder-prostate rhabdomyosarcoma (BP RMS).
We prospectively documented the outcome of children treated in our department between 1991 and 2015 for BP RMS and undergoing a multimodal approach combining conservative surgery (partial cystectomy and/or partial prostatectomy) and perioperative interstitial low-dose-rate or pulse-dose-rate brachytherapy. Before brachytherapy, children had received chemotherapy with modalities depending on their risk group of treatment.
A total of 100 patients were identified, with a median age of 28 months (range, 5.6 months-14 years). According to the Intergroup Rhabdomyosarcoma Study (IRS) group, 84 were IRS-III, and 12 were IRS-IV tumors. Four patients were treated at relapse. The median number of chemotherapy cycles before local therapy was 6 (range, 4-13). After surgery, 63 patients had a macroscopic tumor residuum. Five patients underwent a brachytherapy boost before pelvic external beam radiation therapy because of nodal involvement, and 95 had exclusive brachytherapy. Median follow-up was 64 months (range, 6 months-24.5 years). Five-year disease-free and overall survival rates were 84% (95% confidence interval 80%-88%) and 91% (95% confidence interval 87%-95%), respectively. At last follow-up most survivors presented with only mild to moderate genitourinary sequelae and a normal diurnal urinary continence. Five patients required a secondary total cystectomy: 3 for a nonfunctional bladder and 2 for relapse.
Brachytherapy is effective as part of a conservative strategy for BP RMS, with a relatively low delayed toxicity as compared with previously published studies using external beam radiation therapy. Longer follow-up is required to ensure that the functional results are maintained over time.
报告在一组前瞻性膀胱前列腺横纹肌肉瘤(BP RMS)患儿中,基于部分手术联合近距离放疗的保守治疗策略的结果。
我们前瞻性记录了1991年至2015年在我科接受治疗的BP RMS患儿的治疗结果,这些患儿采用了包括保守手术(部分膀胱切除术和/或部分前列腺切除术)以及围手术期间质低剂量率或脉冲剂量率近距离放疗的多模式治疗方法。在进行近距离放疗之前,患儿根据其治疗风险组接受了不同方案的化疗。
共纳入100例患者,中位年龄为28个月(范围为5.6个月至14岁)。根据横纹肌肉瘤协作组(IRS)分组,84例为IRS-III期,12例为IRS-IV期肿瘤。4例患者在复发时接受治疗。局部治疗前化疗周期的中位数为6个(范围为4至13个)。手术后,63例患者有肉眼可见的肿瘤残留。5例因淋巴结受累在盆腔外照射放疗前接受了近距离放疗强化,95例仅接受了近距离放疗。中位随访时间为64个月(范围为6个月至24.5年)。5年无病生存率和总生存率分别为84%(95%置信区间80%-88%)和91%(95%置信区间87%-95%)。在最后一次随访时,大多数幸存者仅表现出轻度至中度的泌尿生殖系统后遗症,且日间尿失禁正常。5例患者需要二次全膀胱切除术:3例因膀胱无功能,2例因复发。
近距离放疗作为BP RMS保守治疗策略的一部分是有效的,与先前发表的使用外照射放疗的研究相比,延迟毒性相对较低。需要更长时间的随访以确保功能结果随时间得以维持。